Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Quaker Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Quaker Partners

Quaker Partners

Operating

Quaker Partners Management is a US-based venture capital firm specializing in equity investments and management services in healthcare.

Location
Philadelphia, PA, US
Founded
2002
Firm
Compare
Portfolio
Employees

Quaker Partners Management, L.P. operates as a venture capital firm.

The Company makes equity investments in healthcare companies, as well as offers investment management services. Quaker Partners Management serves customers in the United States.

Quaker Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments38
Current Portfolio Count17
Total Portfolio Exits3

Top Investment Stages

Series A11 (33.3%)
Series B8 (24.2%)
Series D5 (15.2%)
Series Unknown5 (15.2%)
Series C4 (12.1%)

Stage Mix

Series A 33%Series B 24%Series D 15%Series Unknown 15%Series C 12%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Kaarta logo

Kaarta

Tela Bio logo

Tela Bio

Rapid Micro Biosystems logo

Rapid Micro Biosystems

Neuronetics logo

Neuronetics

Tarsa Therapeutics logo

Tarsa Therapeutics

NovaSom logo

NovaSom

Corridor Pharmaceuticals logo

Corridor Pharmaceuticals

Helomics logo

Helomics

BioLeap logo

BioLeap

Asensus Surgical logo

Asensus Surgical

Biolex Therapeutics logo

Biolex Therapeutics

Diasome Pharmaceuticals logo

Diasome Pharmaceuticals

Tranzyme logo

Tranzyme

Optherion logo

Optherion

Argolyn Bioscience logo

Argolyn Bioscience

StageMark logo

StageMark

Amicus Therapeutics logo

Amicus Therapeutics

Nitric Bio logo

Nitric Bio

Neotropix logo

Neotropix

Nucleonics logo

Nucleonics

Quaker Partners - Similar Investment Firms

Quaker Capital Investments logo

Quaker Capital Investments

quakercap.com

Qiming Venture Partners USA logo

Qiming Venture Partners USA

qimingvcusa.com

Partisan Management Group logo

Partisan Management Group

Dauphin Capital Partners logo

Dauphin Capital Partners

Venture Equity Partners logo

Venture Equity Partners

Quake Capital Partners logo

Quake Capital Partners

quakecapital.com

Fluke Venture Partners logo

Fluke Venture Partners

Health2047 Capital Partners logo

Health2047 Capital Partners

Penn Venture Partners logo

Penn Venture Partners

QuestMark Partners logo

QuestMark Partners

questm.com

Fannin Partners logo

Fannin Partners

Boston Millennia Partners logo

Boston Millennia Partners

Francisco Partners logo

Francisco Partners

Quark Venture logo

Quark Venture

quarkventure.com

Flare Capital Partners logo

Flare Capital Partners

flarecapital.com

Quaker Partners - Classification

Also Known As
  • Quaker Partners Management, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end